Beyond market averages, investors seeking exceptional growth focus on the art of stock selection. The right picks can significantly contribute to the expansion of your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The closing price of Invesco Ltd (NYSE: IVZ) was $17.62 for the day, up 0.69% from the previous closing price of $17.50. In other words, the price has increased by $0.69 from its previous closing price. On the day, 2.49 million shares were traded. IVZ stock price reached its highest trading level at $17.655 during the session, while it also had its lowest trading level at $17.435.
Ratios:
Our analysis of IVZ’s different ratios will help us gain a deeper understanding of the company. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 4.84 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 6.17. In the meantime, Its Debt-to-Equity ratio is 0.51 whereas as Long-Term Debt/Eq ratio is at 0.51.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Wells Fargo on September 12, 2024, initiated with a Underweight rating and assigned the stock a target price of $16.
On August 27, 2024, Barclays started tracking the stock assigning a Equal Weight rating and target price of $18.
On January 04, 2024, TD Cowen started tracking the stock assigning a Outperform rating and target price of $21.TD Cowen initiated its Outperform rating on January 04, 2024, with a $21 target price.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, IVZ now has a Market Capitalization of 7918428160 and an Enterprise Value of 8916127744. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.35 while its Price-to-Book (P/B) ratio in mrq is 0.75. Its current Enterprise Value per Revenue stands at 1.514 whereas that against EBITDA is 8.385.
Stock Price History:
Over the past 52 weeks, IVZ has reached a high of $18.79, while it has fallen to a 52-week low of $12.48. The 50-Day Moving Average of the stock is 2.84%, while the 200-Day Moving Average is calculated to be 9.52%.
Shares Statistics:
IVZ traded an average of 3.85M shares per day over the past three months and 4525380 shares per day over the past ten days. A total of 449.50M shares are outstanding, with a floating share count of 442.43M. Insiders hold about 1.69% of the company’s shares, while institutions hold 85.73% stake in the company. Shares short for IVZ as of 1727654400 were 6492147 with a Short Ratio of 1.69, compared to 1724976000 on 7805982. Therefore, it implies a Short% of Shares Outstanding of 6492147 and a Short% of Float of 2.42.
Dividends & Splits
With its trailing 12-month dividend rate of 0.815, IVZ has a forward annual dividend rate of 0.81. Against a Trailing Annual Dividend Yield of 0.04657143The stock’s 5-year Average Dividend Yield is 5.25.
